Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,237 | 10,040 | -292,305 | -231,366 | -175,826 |
| Depreciation Amortization | -4,309 | -2,440 | -11,768 | -7,550 | -5,779 |
| Income taxes - deferred | N/A | N/A | -853 | -853 | -853 |
| Other Working Capital | -2,206 | -15,533 | 5,864 | -4,404 | -9,183 |
| Other Operating Activity | -2,361 | -44,041 | 91,240 | 76,950 | 63,083 |
| Operating Cash Flow | $-87,113 | $-51,974 | $-207,822 | $-167,223 | $-128,558 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 96,191 | 61,585 | -43,875 | -1,988 | 115,372 |
| PPE Investments | -156 | -40 | -583 | -410 | -319 |
| Investing Cash Flow | $96,035 | $61,545 | $-44,458 | $-2,398 | $115,053 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 257 | 248 | 237,303 | 237,303 | 236,994 |
| Other Financing Activity | -241 | -241 | 0 | 0 | 0 |
| Financing Cash Flow | $16 | $7 | $237,303 | $237,303 | $236,994 |
| Beginning Cash Position | 30,719 | 30,719 | 45,696 | 45,696 | 45,696 |
| End Cash Position | 39,657 | 40,297 | 30,719 | 113,378 | 269,185 |
| Net Cash Flow | $8,938 | $9,578 | $-14,977 | $67,682 | $223,489 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,113 | -51,974 | -207,822 | -167,223 | -128,558 |
| Capital Expenditure | -221 | -40 | -583 | -410 | -319 |
| Free Cash Flow | -87,334 | -52,014 | -208,405 | -167,633 | -128,877 |